García PE, Flores LEN, Aguilar TDL, Álvarez TLC, López AR

Idioma: Español
Referencias bibliográficas: 8
Paginas: 271-274
Archivo PDF: 288.17 Kb.

RESUMEN

El síndrome antifosfolípido es una enfermedad autoinmune caracterizada por la combinación de trombosis venosa y arterial, cuya forma de presentación es muy diversa. El infarto agudo de miocardio es una de sus presentaciones más inusuales. En este artículo se presenta un caso con este diagnóstico y trombo intracavitario, como forma de presentación del síndrome antifosfolípido.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Prashanth P, Mukhaini M, Riyami A. A rare pre-sentation of primary antiphospholipid syndrome. Oman Med J. 2009;24(4):300-2.

2. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus state-ment on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295-306.

3. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chait-man BR, White HD, et al. Third universal definition of myocardial infarction. Nat Rev Cardiol. 2012; 9(11):620-33.4. Cervera R, Boffa MC, Khamashta MA, Hughes GR. The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus. 2009; 18(10):889-93.

4. Davies JO, Hunt BJ. Myocardial infarction in young patients without coronary atherosclerosis: assume primary antiphospholipid syndrome until proved otherwise. Int J Clin Pract. 2007;61(3):379-84.

5. Miranda CH, Gali LG, Marin-Neto JA, Louzada-Júnior P, Pazin-Filho A. Coronary thrombosis as the first complication of antiphospholipid syndrome. Arq Bras Cardiol. 2012;98(4):66-9.

6. Jurado OM, Durán J, Martínez A, Castellón JM, Gu-tiérrez MA. Acute myocardial infarction in a man without coronary atheromatosis and antiphospho-lipid syndrome: report of one case. Rev Med Chil. 2009;137(11):1478-81.

7. Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, et al. 2009 focused updates: ACC/ AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coro-nary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;54(23):2205-41.

8. Romaguera R, Gómez-Hospital JA, Sánchez-Elvira G, Gómez-Lara J, Ferreiro JL, Roura G, et al. MGuard mesh-covered stent for treatment of ST-segment elevation myocardial infarction with high thrombus burden despite manual aspiration. J Interv Cardiol. 2013 Feb;26(1):1-7.